State Street Corp decreased its position in SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report) by 2.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 1,097,813 shares of the company’s stock after selling 31,353 shares during the quarter. State Street Corp owned 1.54% of SIGA Technologies worth $7,410,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in the company. Larson Financial Group LLC acquired a new position in SIGA Technologies in the third quarter valued at about $30,000. DekaBank Deutsche Girozentrale acquired a new position in shares of SIGA Technologies in the 2nd quarter worth approximately $40,000. AQR Capital Management LLC bought a new stake in SIGA Technologies during the 2nd quarter worth approximately $99,000. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in SIGA Technologies by 38.9% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,684 shares of the company’s stock valued at $104,000 after purchasing an additional 3,829 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. increased its holdings in SIGA Technologies by 64.3% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 13,727 shares of the company’s stock valued at $93,000 after purchasing an additional 5,372 shares in the last quarter. Institutional investors own 55.40% of the company’s stock.
SIGA Technologies Stock Performance
SIGA Technologies stock opened at $5.93 on Friday. The business’s fifty day moving average is $6.67 and its two-hundred day moving average is $7.67. The firm has a market cap of $423.43 million, a P/E ratio of 4.94 and a beta of 0.89. SIGA Technologies, Inc. has a 52 week low of $4.26 and a 52 week high of $12.83.
About SIGA Technologies
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Featured Stories
- Five stocks we like better than SIGA Technologies
- Top Biotech Stocks: Exploring Innovation Opportunities
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- 3 Fintech Stocks With Good 2021 Prospects
- How AI Implementation Could Help MongoDB Roar Back in 2025
- How to invest in marijuana stocks in 7 stepsĀ
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Want to see what other hedge funds are holding SIGA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report).
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.